Mutual tolerance after liver and not after heart transplantation? Evaluation of patient-anti-donor and donor-anti-patient responses by mixed lymphocyte culture.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Transplant Immunology

• Publication date

  1998-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0966-3274(98)80032-4PMID 9640626
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of HLA-DR-shared blood transfusion on the clinical outcome of heart transplantation.

  1997cited by this paper
• Weaning of immunosuppression in liver transplant recipients.

  1997cited by this paper
• Reactive oxygen species-mediated tissue injury in experimental ascending pyelonephritis.

  1996cited by this paper
• Incidence, risk factors, and outcome of antithymocyte globulin treatment of steroid-resistant rejection after liver transplantation

  1996cited by this paper
• Comparison of T cell responses in patients with a long-term surviving renal allograft versus a long-term surviving liver allograft. It's a different world.

  1996cited by this paper
• MICROCHIMERISM LINKED TO CYTOTOXIC T LYMPHOCYTE FUNCTIONAL UNRESPONSIVENESS (CLONAL ANERGY) IN A TOLERANT RENAL TRANSPLANT RECIPIENT

  1995cited by this paper
• Histological and biochemical effects of cyclosporine A withdrawal from a triple drug regimen after over 2 years of treatment in liver transplant patients.

  1995cited by this paper
• Weaning of immunosuppression in long-term recipients of living related renal transplants: a preliminary study.

  1995cited by this paper
• Mechanisms of Action of New Immunosuppressive Drugs

  1995cited by this paper
• Organ-specific patterns of donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimerism in lung, kidney, and liver transplant recipients.

  1995cited by this paper
• Donor microchimerism is not responsible for the maintenance of tolerance to donor alloantigens in recipients tolerant of cardiac allografts.

  1995cited by this paper
• REDUCTION OF DONOR‐SPECIFIC CYTOTOXIC T LYMPHOCYTE PRECURSORS IN PERIPHERAL BLOOD OF ALLOGRAFTED HEART RECIPIENTS

  1994cited by this paper
• Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I.

  1994cited by this paper
• Peripheral microchimerism in long-term cadaveric-kidney allograft recipients.

  1994cited by this paper
• Donor-type microchimerism associated with graft rejection eight years after liver transplantation.

  1994cited by this paper
• Microchimerism frequency two to thirty years after cadaveric kidney transplantation.

  1994cited by this paper
• Prevention by liver transplantation of the graft-versus-host reaction and allograft rejection in a rat model of small bowel transplantation.

  1994cited by this paper
• Murine liver allograft transplantation: Tolerance and donor cell chimerism

  1994cited by this paper
• Organ graft tolerance: the liver effect.

  1994cited by this paper
• Transfusion-associated graft-versus-host disease in immunocompetent patients: a self-protective mechanism.

  1994cited by this paper
• Induction of donor-specific tolerance or sensitization as measured by sequential MLC reactivity up to 24 months after renal transplantation.

  1994cited by this paper
• Induction of donor‐pecific tolerance or sensitization as measured by sequential MLC reactivity up to 24 months after renal transplantation

  1994cited by this paper
• Cell migration and chimerism after whole‐organ transplantation: The basis of graft acceptance

  1993cited by this paper
• Analysis of T cell responses in liver allograft recipients. Evidence for deletion of donor-specific cytotoxic T cells in the peripheral circulation.

  1993cited by this paper
• PASSENGER LYMPHOCYTES IN HUMAN LIVER ALLOGRAFTS AND THEIR POTENTIAL ROLE AFTER TRANSPLANTATION

  1993cited by this paper
• Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation.

  1993cited by this paper
• CHIMERISM AND DONOR‐SPECIFIC NONREACTIVITY 27 TO 29 YEARS AFTER KIDNEY ALLOTRANSPLANTATION

  1993cited by this paper
• Cytokines as mediators of organ graft rejection and tolerance.

  1993cited by this paper
• Clonal deletion of postthymic T cells: veto cells kill precursor cytotoxic T lymphocytes

  1992cited by this paper
• Graft-versus-host disease in solid organ transplantation

  1991cited by this paper
• Resistance to graft-versus-host disease following small bowel transplantation.

  1991cited by this paper
• Blood transfusion and allograft survival: is mixed chimerism the solution for tolerance induction in clinical transplantation?

  1991cited by this paper
• Graft-versus-host resistance induced by class II major histocompatibility complex-specific T cell clones

  1991cited by this paper
• Accessory Cell Signals Involved in T‐Cell Activation

  1990cited by this paper
• Renal transplant patients monitored by the cell-mediated lympholysis assay. Evaluation of its clinical value.

  1989cited by this paper
• Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen

  1989cited by this paper
• SOLUBLE HLA ANTIGENS IN THE CIRCULATION OF LIVER GRAFT RECIPIENTS

  1989cited by this paper
• Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts.

  1989cited by this paper
• Acquired immune tolerance to cadaveric renal allografts. A study of three patients treated with total lymphoid irradiation.

  1989cited by this paper
• In vivo administration of histoincompatible lymphocytes leads to rapid functional deletion of cytotoxic T lymphocyte precursors

  1989cited by this paper
• Specific resistance to local graft-versus-host reaction in F1 hybrids pretreated intravenously with parent-strain spleen cells. Role of cytotoxic T lymphocytes directed against receptors for the major histocompatibility complex.

  1988cited by this paper
• IMPROVED RENAL ALLOGRAFT SURVIVAL FOLLOWING DONOR‐SPECIFIC TRANSFUSIONS: III. Kinetics of Mixed Lymphocyte Culture Responses Before and After Transplantation1

  1988cited by this paper
• HLA regulates postrenal transplant CML nonreactivity.

  1985cited by this paper
• SPECIFIC RECIPIENT‐DONOR UNRESPONSIVENESS MEDIATED BY A SUPPRESSOR CELL SYSTEM IN HUMAN KIDNEY ALLOGRAFT TOLERANCE

  1982cited by this paper
• Induction of Immunological Tolerance by Porcine Liver Allografts

  1969cited by this paper

• Dynamics of Regulatory T cells in Liver Transplantation

  2007cites this paper
• Donor-specific cytotoxic hyporesponsiveness associated with high interleukin-10 messenger RNA expression in cardiac allograft patients.

  2006cites this paper
• Low circulating regulatory T‐cell levels after acute rejection in liver transplantation

  2006influential citation
• Analysis of tolerance in human and nonhuman primates using delayed-type hypersensitivity

  2004cites this paper
• Down‐regulated donor‐specific T‐cell reactivity during successful tapering of immunosuppression after kidney transplantation

  2002cites this paper
• HUMAN LIVER ALLOGRAFT ACCEPTANCE AND THE “TOLERANCE ASSAY”: IN VITRO ANTI-DONOR T CELL ASSAYS SHOW HYPOREACTIVITY TO DONOR CELLS, BUT UNLIKE DTH, FAIL TO DETECT LINKED SUPPRESSION1

  2001cites this paper
• Analysis of post-transplant immune status in recipients of liver/bone marrow allografts.

  1999cites this paper